The patients were then randomized to premeal inhaled human insulin plus twice-daily NPH or to continue on the subcutaneous regimen.

• 随后这些病人被随机分到两组，一组使用餐前吸入型人胰岛素加一日两次的中效胰岛素治疗，另一组继续使用皮下胰岛素注射。